Slingerland, NY, United States of America

Xiaomin Jin


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Xiaomin Jin

Introduction

Xiaomin Jin, based in Slingerland, NY, stands out as a prominent inventor focused on advancements in the field of pharmaceuticals. With two registered patents, his work prominently addresses the pressing issue of opioid abuse, providing innovative solutions aimed at enhancing drug safety.

Latest Patents

Xiaomin Jin's latest patents include methods and compositions for preventing opioid abuse. These patents describe abuse-resistant opioid compounds and encompass drug delivery systems along with pharmaceutical compositions that feature an opioid covalently bound to a chemical moiety. Additionally, they outline methods of delivering an active ingredient to a subject and strategies for preventing opioid abuse. Through these innovations, Jin aims to significantly reduce the risk associated with opioid medications.

Career Highlights

Throughout his career, Xiaomin Jin has made significant contributions to pharmaceutical research and development. He has been associated with reputable companies, including Albany Molecular Research, Inc. and 3ST Research LLC, where he developed cutting-edge methodologies that address critical health concerns.

Collaborations

Xiaomin Jin has collaborated with notable professionals in the field, including colleagues Matthew Surman and Kathryn Golden. Their combined expertise supports the development of innovative solutions that promote safer drug delivery systems.

Conclusion

Xiaomin Jin's inventive work exemplifies a crucial commitment to addressing one of today's most significant public health challenges. Through his patents and collaborative efforts, Jin is making meaningful strides toward minimizing opioid addiction risks, demonstrating the profound impact of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…